Eli Lilly caps insulin costs at $35 per month
The drugmaker Eli Lilly is cutting prices for its insulin and capping costs at $35 per month, the company said...
Read moreLatest Post
COVID origin tensions test Biden’s China balancing act
President Biden’s balancing act with China is being tested by renewed pressure from Republicans to confront Beijing over the origins...
Read more
At-home cardiac rehabilitation may lower risk of death: study
Veterans who participated in a home-based cardiac rehabilitation program had a 36 percent lower risk of mortality compared to people...
Read more
SNAP cuts could lead to ‘hunger cliff,’ experts fear
A pandemic-related boost in the Supplemental Nutrition Assistance Program (SNAP) will be cut in every state on March 1, meaning millions of...
Read more
These states have extended Medicaid coverage for new mothers
The Mississippi state legislature moved one step closer this week to expanding Medicaid coverage for new mothers up to a...
Read more
Why a final answer on COVID-19’s origins remains out of reach
The Department of Energy's recent conclusion that COVID-19 likely originated from a Chinese research lab has reignited debate over whether...
Read more
FDA panel narrowly endorses Pfizer vaccine for RSV in older adults
A panel of outside advisers to the Food and Drug Administration (FDA) narrowly voted in favor of the country's first...
Read more
Experts say FDA needs more regulatory flexibility
Strict regulations on drug safety and testing make it difficult to develop new treatments for rare, obscure and deadly diseases,...
Read more
Mississippi bans gender-affirming health care for trans minors
Mississippi Gov. Tate Reeves (R) on Tuesday gave final approval to legislation that bars medical professionals from providing gender-affirming health...
Read more
FDA restricts imports of ‘tranq’ drug xylazine
The Food and Drug Administration (FDA) on Tuesday said it would restrict imports of xylazine, an animal tranquilizer that has...
Read more
